REXO2 and breast cancer: Cell-based work confirmed that silencing REXO2 greatly inhibited cell proliferation and induced apoptosis in BC.<h4>Conclusions</h4>Our proposed MPAS could effectively evaluate the prognosis and treatment response of BC patients, providing new reference for clinical decision-making.